{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:59:12Z","timestamp":1789405152482,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bone.2019.06.025","type":"journal-article","created":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T19:38:39Z","timestamp":1562096319000},"page":"386-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients"],"prefix":"10.1016","volume":"127","author":[{"given":"Sean","family":"DeLacey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Broyles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"El-Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian F.","family":"Guandique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin C.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7284-3467","authenticated-orcid":false,"given":"Erik A.","family":"Imel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0005","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1530\/EJE-08-0818","article-title":"Incidence and prevalence of nutritional and hereditary rickets in southern Denmark","volume":"160","author":"Beck-Nielsen","year":"2009","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","volume":"11","year":"1995","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.bone.2019.06.025_bb0015","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"11","key":"10.1016\/j.bone.2019.06.025_bb0020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneph.2010.121","article-title":"Hereditary disorders of renal phosphate wasting","volume":"6","author":"Alizadeh Naderi","year":"2010","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"10.1016\/j.bone.2019.06.025_bb0025","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J. Bone Miner. Res."},{"issue":"1","key":"10.1016\/j.bone.2019.06.025_bb0030","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0035","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00467-002-1044-6","article-title":"Hypertension in hypophosphatemic rickets\u2013role of secondary hyperparathyroidism","volume":"18","author":"Alon","year":"2003","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0040","first-page":"150","article-title":"Co-existence of X-linked hypophosphatemic rickets (XLH) and primary hyperparathyroidism: case report and review of the literature","volume":"5","author":"Tournis","year":"2005","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S0002-9343(70)80032-8","article-title":"Parathyroid adenomas in chronic rickets","volume":"49","author":"Thomas","year":"1970","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.bone.2019.06.025_bb0050","first-page":"1514","article-title":"Tertiary hyperparathyroidism during high phosphate therapy of familial hypophosphatemic rickets","volume":"75","author":"Rivkees","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0055","first-page":"266","article-title":"Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets","volume":"11","author":"Tournis","year":"2011","journal-title":"J. Musculoskelet. Neuronal Interact."},{"issue":"6","key":"10.1016\/j.bone.2019.06.025_bb0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2169\/internalmedicine.39.468","article-title":"Tertiary hyperparathyroidism in X-linked hypophosphatemic rickets","volume":"39","author":"Wu","year":"2000","journal-title":"Intern. Med."},{"issue":"4","key":"10.1016\/j.bone.2019.06.025_bb0065","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0002-9343(85)90411-5","article-title":"Development of hypercalcemic hyperparathyroidism after long-term phosphate supplementation in hypophosphatemic osteomalacia. Report of two cases","volume":"78","author":"Firth","year":"1985","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.bone.2019.06.025_bb0070","first-page":"1378","article-title":"Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia","volume":"78","author":"Carpenter","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0075","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2265.1995.tb01863.x","article-title":"Autonomous hyperparathyroidism in X-linked hypophosphataemia","volume":"42","author":"Knudtzon","year":"1995","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0080","doi-asserted-by":"crossref","first-page":"274","DOI":"10.14310\/horm.2002.1277","article-title":"Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review","volume":"9","author":"Yavropoulou","year":"2010","journal-title":"Hormones (Athens)"},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0085","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archsurg.139.2.218","article-title":"Parathyroidectomy for tertiary hyperparathyroidism associated with X-linked dominant hypophosphatemic rickets","volume":"139","author":"Savio","year":"2004","journal-title":"Arch. Surg."},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4274\/jcrpe.3486","article-title":"The effectiveness of cinacalcet as an adjunctive therapy for hereditary 1,25 dihydroxyvitamin D3-resistant rickets","volume":"9","author":"Akinci","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0095","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2215\/CJN.04981107","article-title":"Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets","volume":"3","author":"Alon","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2019.06.025_bb0100","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1530\/EJE-08-0383","article-title":"A case of X-linked hypophosphatemic rickets: complications and the therapeutic use of cinacalcet","volume":"159","author":"Raeder","year":"2008","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.bone.2019.06.025_bb0105","first-page":"39","article-title":"Hyperparathyroidism in patients with X-linked dominant hypophosphatemic rickets\u2013application of the calcium infusion test as an indicator for parathyroidectomy","volume":"5","author":"Alon","year":"1984","journal-title":"Int J Pediatr Nephrol"},{"issue":"3","key":"10.1016\/j.bone.2019.06.025_bb0110","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1507\/endocrj.EJ16-0199","article-title":"Hypertension is a characteristic complication of X-linked hypophosphatemia","volume":"64","author":"Nakamura","year":"2017","journal-title":"Endocr. J."},{"issue":"7","key":"10.1016\/j.bone.2019.06.025_bb0115","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr. Nephrol."},{"issue":"5","key":"10.1016\/j.bone.2019.06.025_bb0120","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","article-title":"The enigma of hyperparathyroidism in hypophosphatemic rickets","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.bone.2019.06.025_bb0125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","article-title":"Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets","volume":"58","author":"Makitie","year":"2003","journal-title":"Clin. Endocrinol."},{"issue":"4","key":"10.1016\/j.bone.2019.06.025_bb0130","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1210\/jc.2009-1671","article-title":"Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations","volume":"95","author":"Imel","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.bone.2019.06.025_bb0135","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","article-title":"Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status","volume":"95","author":"Carpenter","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.bone.2019.06.025_bb0140","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219302571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328219302571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:48:36Z","timestamp":1757612916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328219302571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":28,"alternative-id":["S8756328219302571"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2019.06.025","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperparathyroidism and parathyroidectomy in X-linked hypophosphatemia patients","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2019.06.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}